Skip to main content

Table 3 Demographic and surgery variables. Data are mean (SD) or number of dogs (%)

From: Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial

Variable

Robenacoxib

Meloxicam

Total

P value*

Number of dogs

118

56

174

 

Age (years)

5.9 (3.9)

5.2 (4.1)

5.7 (3.9)

0.20

Body weight (kg)

20.8 (12.3)

19.0 (11.1)

20.2 (11.9)

0.42

Sex and neutered status

    

Male not neutered

14 (11.9%)

8 (14.3%)

22 (12.6%)

0.37

Female not neutered

87 (73.7%)

40 (71.4%)

127 (73.0%)

Male neutered

5 (4.2%)

0 (0%)

5 (2.9%)

Female neutered

12 (10.2%)

8 (14.3%)

20 (11.5%)

Pre-surgery pain (VAS)

    

 ▪ At rest

2.0 (5.4)

1.7 (2.3)

1.9 (4.6)

0.21

 ▪ At palpation/manipulation

5.2 (10.2)

4.2 (6.3)

4.9 (9.2)

0.64

Type of surgery**

    

 ▪ Ovariectomy

37 (31%)

22 (39%)

59 (34%)

0.31

 ▪ Ovario-hysterectomy

28 (24%)

10 (18%)

38 (22%)

0.44

 ▪ Mammary chain excision

30 (25%)

15 (27%)

45 (26%)

0.85

 ▪ Gastro-intestinal surgery

5 (4%)

0 (0%)

5 (3%)

0.18

 ▪ Genito-urinary surgery

5 (4%)

2 (4%)

7 (4%)

1.0

 ▪ Thoracic surgery

1 (1%)

0 (0%)

1 (1%)

1.0

 ▪ Other soft tissue surgery

22 (19%)

10 (18%)

32 (18%)

1.0

Duration of surgery (hours)

0.85 (0.52)

0.68 (0.35)

0.79 (0.48)

0.037

Duration of intubation (hours)

1.4 (0.77)

1.2 (0.60)

1.3 (0.73)

0.20

Time between injection of robenacoxib or meloxicam and extubation (hours)

1.6 (0.81)

1.4 (0.63)

1.5 (0.76)

0.18

Duration of oral dosing (days)

11.3 (22.2)

10.9 (3.0)

-

0.92

  1. Data are mean (SD) or number of dogs (%).
  2. * Significance of differences between treatment groups (Kruskal-Wallis or Mann–Whitney U tests).
  3. ** Some dogs underwent two surgeries during the same anesthesia.